Xcout IntelPasithea Therapeutics Corp.
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.
Subscribe to see Pasithea Therapeutics Corp.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Pasithea Therapeutics Corp. at a glance
Pasithea Therapeutics Corp. is a biotech company headquartered in Miami Beach, United States. It is publicly listed (KTTA) with a market capitalisation of $14.7M. Xcout tracks 10 named people at Pasithea Therapeutics Corp., including Tiago Reis Marques (Chief Executive Officer & Director).
Pasithea Therapeutics Corp. leadership
- Tiago Reis MarquesChief Executive Officer & Director
- Daniel H. SchneidermanChief Financial Officer
- Kartik KrishnanChief Medical Officer
- Lawrence SteinmanCo-Founder & Executive Chairman
- Alfred J NovakDirector
- David DelaneyDirector
4 more named people on record for Pasithea Therapeutics Corp., with roles, board committees and tenure — see the full roster →
Investors
Pasithea Therapeutics Corp. competitors
A few of Pasithea Therapeutics Corp.'s closest competitors — see the full list of competitors and alternatives →
Gilgamesh Pharma Inc. is a clinical-stage neuroscience company that develops novel chemical entities to treat psychiatric diseases, aiming to move beyond symptom management toward rapid-acting and durable therapies. The company utilizes an AI-powered discovery platform and medicinal chemistry to create precision therapies targeting conditions such as depression, anxiety, addiction, and schizophrenia.
AtaiBeckley Inc. has its corporate headquarters located in New York, USA. The biopharmaceutical company is on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments.
Beckley Psytech is a UK-based clinical-stage biotechnology company developing psychedelic medicines for psychiatric and neurological disorders. Its programs have included BPL-003, an intranasal formulation of 5-MeO-DMT, intended for conditions such as treatment-resistant depression and alcohol use disorder.
Lykos Therapeutics is a biotechnology company developing psychedelic-assisted therapies, particularly MDMA-assisted therapy for post-traumatic stress disorder (PTSD). It works with clinicians and researchers to advance regulated treatments for people with PTSD and related mental-health conditions.
ATAI Life Sciences AG is a biopharmaceutical company headquartered in Munich, Germany, focused on acquiring and developing innovative treatments for mental health disorders.
Elkedonia is a biotechnology company committed to introducing a pioneering, first-in-class antidepressant treatment utilizing precision medicine. Headquartered in Strasbourg, France, the company brings together stakeholders across the European ecosystem to advance innovative therapeutics.
Get Pasithea Therapeutics Corp.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Pasithea Therapeutics Corp. in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 3 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access